Yes, and that was Goldman Small Cap Research as yo

Yes, and that was Goldman Small Cap Research as you stated, and NOT Goldman Sachs. Some have confused the two in the past. They predicted .11 by years end, but that was based on material knowledge available to them as of February 15th when they published that report. You have to go to Goldman's website and download the report to get the full report, but I posted that part of it below.
http://www.goldmanresearch.com/201802151201/O...arket.html

ROCKY MOUNTAIN HIGH BRANDS, INC.
Hemp Brands Pioneer Set to Return to New Highs
Rob Goldman February 15, 2017
rob@goldmanresearch.com
ROCKY MOUNTAIN HIGH BRANDS, INC. (OTCQB – RMHB - Price - $0.0167)
NT Price Target: $0.07, 1 Year Target: $0.11 Rating: Speculative Buy
COMPANY SNAPSHOT
Rocky Mountain High Brands, Inc. (RMHB)
specializes in developing, manufacturing,
marketing, and distributing high-quality, health
conscious, hemp-infused products that span
various “good for you categories”. The Company
currently markets a lineup of naturally flavored
hemp-infused functional beverages. RMHB also
bottles and distributes naturally-high alkaline spring
water under the name Eagle Spirit Spring Water.
In early 2018, the Company introduced HEMPd,
RMHB’s broad hemp-derived, CBD-infused product
line, led by its flagship CBD-infused waters.
KEY STATISTICS
Price as of 2/14/18 $0.167
52 Week High – Low $0.153 - $0.0053
Est. Shares Outstanding 1,368.2B
Market Capitalization $22.8M
Average Volume 31,676,000
Exchange OTCQB
COMPANY INFORMATION
Rocky Mountain High Brands, Inc.
9101 LBJ Freeway
Suite 200
Dallas TX 75243
Website: rockymountainhighbrands.com/
Email: michael@rockymountainhighbrands.com
INVESTMENT HIGHLIGHTS
A high profile brand in the hemp-infused food and
beverage arena, RHMB is poised to serve as the
category leader in the exciting, fast-growing
hemp-derived CBD products consumer segment.
The RMHB leadership is second to none and is
worth more than the current market cap alone.
Aided by management and advisors that include a
former beverage company CEO, the founder of the
infomercial, and a former Coca-Cola executive,
RMHB’s new suite of product introductions in early
2018 should quickly capture meaningful market share.
A new report issued by the World Health
Organization (WHO) notes that CBDs carry
potential therapeutic benefits for those suffering
from serious diseases and conditions. Thus, the
overall CBD market is forecast to grow from $262M in
2016 to $1.15B in 2020.
RMHB just closed the largest deal in company
history, and one of the largest in the industry---
worth $7.2M in 2018 revenue. This deal should
cement RMHB as a top 5 player in the CBD-infused
beverage industry this year and affords it significant
financial visibility and flexibility.
In our view, RMHB’s stock is “on sale” and will be
afforded a substantial increase in value in the
near term on the heels of its new contract and
ahead of new product introductions. Moreover,
the stock trades at a huge discount to its peer
group. Our near term $0.07 target price reflects the
average valuation afforded RMHB’s peers, and we
believe the stock could trade at a premium to this
level later this year as it generates meaningful revenue.
We rate these shares Speculative Buy.